| 摘要 |
The present invention provides a method to diagnose preeclampsia comprising measuring methylation level of at least one gene selected from the group consisting of CPLX2, KIAA1609, MFAP2, CD80, KRT23, PKHD1, STMN2, RAP1A, UBE2G2, KHDC1, SERPINA9, SERPINA5 and PLEKHA2 in a first biological sample from a subject; and diagnosing preeclampsia in said subject based on a higher or lower methylation level in the first biological sample relative to the methylation level in a second biological sample from an individual without preeclampsia or control. |
